Welcome to the international HTA database

Showing [23368 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Patient information on interstitial low-dose-rate brachytherapy for localized prostate cancer - addendum to commission N17-04]
2020	Health Technology Wales (HTW)	Single-operator per-oral cholangioscopy for the management of hepatobiliary-pancreatic disorders
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures unresponsive to non-surgical treatment
2020	Health Technology Wales (HTW)	Remote monitoring of blood glucose in women with gestational diabetes
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Polatuzumab Vedotin (Diffuse Large B-Cell Lymphoma, Combination with Bendamustine and Rituximab)]
2020	National Authority for Assessment and Accreditation in Healthcare (INEAS)	Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Ponatinib (Reassessment after the Deadline: Chronic Myeloid Leukaemia)]
2020	National Authority for Assessment and Accreditation in Healthcare (INEAS)	Chloroquine et Hydroxychloroquine dans le traitement de la COVID-19
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Ponatinib (Reassessment after the Deadline: Acute Lymphoblastic Leukaemia)]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Guideline synopsis for the DMP "type 2 diabetes"]
2020	National Authority for Assessment and Accreditation in Healthcare (INEAS)	Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19 : Complément d’informations du 22 Mai 2020
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	The treatment of primary hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
2020	NIHR Health Technology Assessment programme	Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis (CRAMMS)
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Tisagenlecleucel (Reassessment after Expiry: B-cell Acute Lymphoblastic Leukaemia)]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Chondroitin sulfate in osteoarthritis
2020	NIHR Public Health Research (PHR) programme	Understanding the impact of tobacco tax increases and tobacco industry pricing on smoking behaviours and inequalities
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Tisagenlecleucel (reassessment after expiry: diffuse large B-cell lymphoma)]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Subacromial decompression for rotator cuff disease
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Volanesorsen]
2020	NIHR Health Technology Assessment programme	Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures unresponsive to non-surgical treatment [HTA scoping report protocol]
2020	Andalusian Health Technology Assessment Area (AETSA)	Cognitive training effectiveness for mild to moderate dementia patients. A systematic review
2020	National Authority for Assessment and Accreditation in Healthcare (INEAS)	[Disinfection chambers/tunnels in the context of COVID-19 pandemic]
2020	Andalusian Health Technology Assessment Area (AETSA)	Genetic risk prediction test for cardiovascular disease
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Intrauterine ultrasound-guided radiofrequency ablation
2020	Canary Health Service	[HPV vaccination in adolescent boys: cost-effectiveness and budget impact]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020	Andalusian Health Technology Assessment Area (AETSA)	Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020	European Network for Health Technology Assessment (EUnetHTA)	Hypoglossal nerve stimulation systems for treatment of obstructive sleep apnea
2020	Andalusian Health Technology Assessment Area (AETSA)	Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2020	Canary Health Service	[Monitoring study: “Endobronchial valves for persistent air leak”]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020	NIHR Health Technology Assessment programme	Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review
2020	European Network for Health Technology Assessment (EUnetHTA)	Biodegradable rectum spacers to reduce toxicity for prostate cancer
2020	NIHR Health Technology Assessment programme	Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT
2020	European Network for Health Technology Assessment (EUnetHTA)	The 24-hour blood pressure measurement device Mobil-O-Graph® with the built-in algorithm ARCSolver® to measure arterial stiffness for the optimization of hypertension treatment and assessment of cardiovascular disease risk
2020	NIHR Health Technology Assessment programme	Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020	NIHR Health Technology Assessment programme	Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study
2020	NIHR Health Services and Delivery Research programme	Medication management in older people: the MEMORABLE realist synthesis
2020	European Network for Health Technology Assessment (EUnetHTA)	Lung cancer screening in risk groups
2020	NIHR Health Technology Assessment programme	Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020	European Network for Health Technology Assessment (EUnetHTA)	Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic
2020	European Network for Health Technology Assessment (EUnetHTA)	Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of SARS-COV-2 virus in people with suspected COVID-19
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Moving on from 2020 and looking forward to 2021 with a new and continuous publication model
2020	NIHR Health Technology Assessment programme	Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
2020	European Network for Health Technology Assessment (EUnetHTA)	Lopinavir and ritonavir for the treatment of COVID-19
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	ASERNIP-S: unusual acronym, outstanding results
2020	Norwegian Institute of Public Health (NIPH)	Abdominal aorta aneurysm (AAA) screening of men aged 65
2020	Malaysian Health Technology Assessment (MaHTAS)	Pulsed electromagnetic field therapy – an update
2020	Malaysian Health Technology Assessment (MaHTAS)	Repetitive transcranial magnetic stimulation (rTMS) for patients with stroke
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib (new therapeutic indication, chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Proposal for the organization of bariatric medicine for the territories of the integrated university health and social services network of Laval University]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Exploratory evaluation of the relevance, use, and impacts of teleconsultations]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Field evaluation of the implementation of video teleconsultations during the COVID-19 pandemic at the Quebec Heart and Lung Institute]
2020	NIHR Health Services and Delivery Research programme	Enhancing the credibility, usefulness and relevance of patient experience data in services for people with long-term physical and mental health conditions using digital data capture and improved analysis of narrative data (DEPEND)
2020	NIHR Health Services and Delivery Research programme	The role of hospital organisation, surgical factors, and the enhanced recovery pathway, on patient outcomes and NHS costs following primary hip and knee replacement surgery: spatial and longitudinal analysis of routine data
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ropeginterferon alfa-2b (polycythaemia vera) - Benefit assessment according to §35a Social Code Book V]
2020	NIHR Health Services and Delivery Research programme	Implementation of an evidence based pelvic floor muscle training intervention for women with pelvic organ prolapse (PROlapse and PFMT: implementing Evidence Locally - PROPEL)
2020	Health Technology Wales (HTW)	Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2020	NIHR Health Services and Delivery Research programme	ERA Electronic Records in Ambulances to support the shift to out of hospital care: challenges, opportunities and workforce implications
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020	NIHR Health Services and Delivery Research programme	Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences
2020	National Institute for Health and Care Excellence (NICE)	Swallowable gastric balloon capsule for weight loss. NICE interventional procedures guidance 684
2020	NIHR Health Technology Assessment programme	Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs
2020	National Institute for Health and Care Excellence (NICE)	Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis. NICE interventional procedures guidance 681
2020	NIHR Health Technology Assessment programme	Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2020	National Institute for Health and Care Excellence (NICE)	Balloon cryoablation for Barrett's oesophagus. NICE interventional procedures guidance 682
2020	NIHR Health Technology Assessment programme	Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Atezolizumab (NSCLC, combination chemotherapy with nab-paclitaxel) - Benefit assessment according to §35a Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Balloon cryoablation for squamous dysplasia of the oesophagus. NICE interventional procedures guidance 683
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Canary Health Service	[Cost-effectiveness of universal childhood vaccination against hepatitis A (update)]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Personal protective equipment and evidence-based advice for surgical departments during COVID-19
2020	National Institute for Health and Care Excellence (NICE)	Transcranial magnetic stimulation for auditory hallucinations. NICE interventional procedures guidance 680
2020	NIHR Health Technology Assessment programme	An online randomised controlled trial to evaluate the clinical and cost effectiveness of a peer supported self-management intervention for relatives of people with psychosis or bipolar disorder: Relatives Education And Coping Toolkit (REACT)
2020	Swiss Federal Office of Public Health (FOPH)	Dual antiplatelet therapy following percutaneous coronary intervention
2020	Canary Health Service	[Liquid biopsy for the detection of ovarian or endometrial cancer in samples taken from the Pap smear: PapSEEK]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cannabidiol (Dravet syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Surgery triage during the COVID-19 pandemic
2020	National Institute for Health and Care Excellence (NICE)	Deep brain stimulation for refractory epilepsy in adults. NICE interventional procedures guidance 678
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cannabidiol (Lennox-Gastaut syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Screening and testing for COVID-19 before surgery
2020	National Institute for Health and Care Excellence (NICE)	Implanted vagus nerve stimulation for treatment-resistant depression. NICE interventional procedures guidance 679
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V - rapid report]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Safe surgery during the coronavirus disease 2019 crisis
2020	National Institute for Health and Care Excellence (NICE)	Transcranial magnetic stimulation for obsessive-compulsive disorder. NICE interventional procedures guidance 676
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Surgery triage: responding to the COVID-19 pandemic. A rapid review comissioned by RACS
2020	National Institute for Health and Care Excellence (NICE)	Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease. NICE interventional procedures guidance 677
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Asfotase alfa (hypophosphatasia) - Benefit assessment according to §35a Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Guidelines for safe surgery: open versus laparoscopic. A rapid review commissioned by RACS
2020	National Institute for Health and Care Excellence (NICE)	Artificial iris insertion for acquired aniridia. NICE interventional procedures guidance 674
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in hematology]
2020	Swiss Federal Office of Public Health (FOPH)	Vitamin D testing
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Larotrectinib (solid tumours) - Benefit assessment according to §35a Social Code Book V]